Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXV6GY
|
||||
| Drug Name |
[(3,4,5-Trimethoxyphenyl)-(4-methoxy,5-hydroxyphenyl)-ketone]thiosemicarbazone
|
||||
| Synonyms |
CHEMBL1271602
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C18H21N3O5S
|
||||
| Canonical SMILES |
COc1ccc(cc1O)\\C(=N/NC(=S)N)\\c2cc(OC)c(OC)c(OC)c2
|
||||
| InChI |
InChI=1S/C18H21N3O5S/c1-23-13-6-5-10(7-12(13)22)16(20-21-18(19)27)11-8-14(24-2)17(26-4)15(9-11)25-3/h5-9,22H,1-4H3,(H3,19,21,27)/b20-16+
|
||||
| InChIKey |
AJHVVOQAFZABFE-CAPFRKAQSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.